Research snapshot · Not reviewed

ABTAbbott Laboratories

CGM + cardiac/rhythm devices

Open ABT in Robinhood ↗

WATCH

Conviction●○○○○1 of 5

Research target—Snapshot target

Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed

Market cap$166.17BSnapshot value

The thesis

CGM market leader (~53% of shipments) + diversified med-tech/diagnostics. FreeStyle Libre franchise. Lingo/Libre Rio OTC. Diversified revenue base reduces single-product risk.

Catalysts

FreeStyle Libre OTC expansion; Lingo wellness CGM; diversified revenue (diagnostics, med-tech, nutrition) provides stability; dividend compounder.

What breaks it

Diversification reduces CGM purity; 5-year underperformance vs broad equities; med-tech segment cyclicality; GLP-1 long-term diabetes disruption.

Social sentiment

needs X/Reddit sentiment sweep

Snapshot · Not reviewed

Smart money

🟢 Confirmed · ins+$1.3M(3buy👥) · 13F 14+/10- · short↑0.16

Snapshot · Not reviewed